EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes

Fozia Ahmed, Susanne Hetty iD, Rutger Laterveer, Ece Busra Surucu, Argyri Mathioudaki, Edvin Hornbrinck, Vagia Patsoukaki, Johan Olausson, Magnus Sundbom, Maria K Svensson, Maria J Pereira iD, Jan W Eriksson iD

The Journal of Clinical Endocrinology & Metabolism · 16.09.2025 · 110 (10) · e3410-e3424

DOI: 10.1210/clinem/dgaf038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 21.01.2025. Verfasst von Fozia Ahmed und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Aromatase, Obesity, Estrogen Receptor alpha. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Diabetes Foundation, Swedish National Strategic Research Initiative EXODIAB (Excellence of Diabetes Research in Sweden), the Family Ernfors Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Obesity and insulin resistance in men are linked to decreased testosterone and increased estradiol (E2) levels. Aromatase (ARO) converts testosterone into E2, and this occurs mainly in adipose tissue in men. E2 acts through estrogen receptors ESR1 and ESR2, and they potentially affect development of type 2 diabetes (T2D).

Objective

This study explored alterations in ARO, ESR1, and ESR2 in men with obesity or T2D.

Methods

Subcutaneous adipose tissue (SAT) from men with or without obesity or T2D was analyzed for ARO, ESR1, and ESR2 gene and protein expression. Data were compared across groups and correlated with markers of obesity, glycemia, insulin resistance, and sex hormones. Moreover, SAT was incubated with E2 or testosterone for ex vivo glucose uptake measurements.

Results

ARO levels were higher in SAT from men with obesity compared to nonobese men, and gene expression correlated positively with adiposity, hyperglycemia, and insulin resistance. No association was found between ARO and circulating E2. Men with obesity had lower levels of ESR1 and ESR1:ESR2 ratio, but not ESR2. ESR1 gene expression in SAT correlated negatively with adiposity and insulin resistance markers as well as with ARO expression, and tended to be lower in men with T2D. E2 reduced insulin-stimulated glucose uptake, while testosterone increased basal glucose uptake in adipocytes.

Conclusion

Elevated ARO in SAT was found in obese men, and this was linked to insulin resistance and glycemia, supporting the idea that local estrogen production contributes to metabolic dysregulation. ESR1 was reduced in men with T2D and was linked to adiposity and insulin resistance. Taken together, high ARO and altered ESR1:ESR2 balance in SAT in obese men may contribute to insulin resistance and T2D development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AromataseObesityEstrogen Receptor alphaEstrogen Receptor betaSubcutaneous FatAdipose TissueHumansMaleMiddle AgedInsulin ResistanceAdultEstradiolAgedTestosterone

Stichwörter der Autor:innen

T2Dadipose tissuearomataseestradiolestrogen receptorsobesity

Substanzen

AromataseEstrogen Receptor alphaESR1 protein, humanEstrogen Receptor betaESR2 protein, humanEstradiolTestosterone

Autor:innen und Institutionen

  • Department of Medical Sciences, Clinical Diabetology and Metabolism, Uppsala University, 751 85 Uppsala, Sweden.
  • Department of Medical Sciences, Clinical Chemistry, Uppsala University, 751 85 Uppsala, Sweden.
  • Department of Laboratory Medicine, Clinical Chemistry, Östersund Hospital, 831 31 Östersund, Sweden.
  • Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden.
  • Department of Medical Sciences, Renal Medicine, Uppsala University, 751 85 Uppsala, Sweden.

ORCID-Profile: Susanne Hetty, Maria J Pereira, Jan W Eriksson

Förderung

  • Swedish Diabetes Foundation
  • Swedish National Strategic Research Initiative EXODIAB (Excellence of Diabetes Research in Sweden)
  • the Family Ernfors Foundation
  • P.O Zetterlings Foundation
  • Swedish Society for Medical Research (SSMF)
  • AstraZeneca R&D
  • NovoNordisk Foundation
  • Agnes and Mac Rudberg Foundation

Zitieren

APA

Ahmed, F., Hetty, S., Laterveer, R., Surucu, E. B., Mathioudaki, A., Hornbrinck, E., Patsoukaki, V., Olausson, J., Sundbom, M., Svensson, M. K., Pereira, M. J., & Eriksson, J. W. (2025). Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 110(10), e3410-e3424. https://doi.org/10.1210/clinem/dgaf038

Vancouver

Ahmed F, Hetty S, Laterveer R, Surucu EB, Mathioudaki A, Hornbrinck E, et al. Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025;110(10):e3410-e3424. doi:10.1210/clinem/dgaf038

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Fozia and Hetty, Susanne and Laterveer, Rutger and Surucu, Ece Busra and Mathioudaki, Argyri and Hornbrinck, Edvin and Patsoukaki, Vagia and Olausson, Johan and Sundbom, Magnus and Svensson, Maria K and Pereira, Maria J and Eriksson, Jan W},
  title = {Altered Expression of Aromatase and Estrogen Receptors in Adipose Tissue From Men With Obesity or Type 2 Diabetes},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {10},
  pages = {e3410--e3424},
  doi = {10.1210/clinem/dgaf038}
}
Kostenlos starten →